Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice

International Archives of Allergy and Immunology

Volumn 145, Issue 4, 2008, Pages 277-282

  Tanizaki, Hideaki ^a   Kambe, Naotomo ^a,b   Nakamura, Yuumi ^b   Tanaka, Akane ^c   Matsuda, Hiroshi ^c   Miyachi, Yoshiki ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Antihistamines; Atopic dermatitis animal model; Bepotastine besilate; Leukotriene B4; NC Nga mice; SCLABA system; Scratching behavior

Indexed keywords

BETOTASTINE; COMPOUND 48-80; LEUKOTRIENE B4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; DRUG EFFECT; DRUG EFFICACY; ECZEMA; EOSINOPHIL COUNT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCRATCHING;

ADMINISTRATION, ORAL; ANIMALS; ANTIPRURITICS; BEHAVIOR, ANIMAL; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; P-METHOXY-N-METHYLPHENETHYLAMINE; PIPERIDINES; PRURITUS; PYRIDINES;

EID: 40949093644     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110886     Document Type: Article

References (16)

1. Wahlgren CF: Itch and atopic dermatitis: an overview. J Dermatol 1999;26:770-779.
2. Aioi A, Tonogaito H, Suto H, Hamada K, Ra CR, Ogawa H, Maibach H, Matsuda H: Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis. Br J Dermatol 2001;144:12-18.
3. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C: Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997;9:461-466.
4. Matsumoto M, Itakura A, Tanaka A, Fujisawa C, Matsuda H: Inability of IL-12 to down-regulate IgE synthesis due to defective production of IFN-gamma in atopic NC/Nga mice. J Immunol 2001;167:5955-5962.
5. Matsumoto M, Ra C, Kawamoto K, Sato H, Itakura A, Sawada J, Ushio H, Suto H, Mitsuishi K, Hikasa Y, Matsuda H: IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J Immunol 1999;162:1056-1063.
6. Kato M, Nishida A, Aga Y, Kita J, Kudo Y, Narita H, Endo T: Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent bepotastine besilate. Arzneimittelforschung 1997;47:1116-1124.
7. Hiroi J, Sengoku T, Morita K, Kishi S, Sato S, Ogawa T, Tsudzuki M, Matsuda H, Wada A, Esaki K: Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice. Jpn J Pharmacol 1998;76:175-183.
8. Sakai A, Kikuchi M, Yato N, Kikkawa S, Saito N, Narita H: Inhibitory effect of bepotastine besilate on antigen-induced airway eosinophil infiltration and peripheral blood eosinophilia in mice. Arzneimittelforschung 1997;47:954-958.
9. Hideo Y, Hiroshi M, Teruo M, Kiyoshi B, Tadashi S: Phase I study of TAU-284 - single oral administration in healthy male volunteers. J Clin Ther Med 1997;13:1137-1153.
10. 4 action in mice. Eur J Pharmacol 2006;547:59-64.
11. Orito K, Chida Y, Fujisawa C, Arkwright PD, Matsuda H: A new analytical system for quantification scratching behaviour in mice. Br J Dermatol 2004;150:33-38.
12. Benyon RC, Church MK, Clegg LS, Holgate ST: Dispersion and characterisation of mast cells from human skin. Int Arch Allergy Appl Immunol 1986;79:332-334.
13. Barrett KE, Ali H, Pearce FL: Studies on histamine secretion from enzymically dispersed cutaneous mast cells of the rat. J Invest Dermatol 1985;84:22-26.
14. Kuraishi Y, Nagasawa T, Hayashi K, Satoh M: Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol 1995;275:229-233.
15. Beltrani VS: Suggestions regarding a more appropriate understanding of atopic dermatitis. Curr Opin Allergy Clin Immunol 2005;5:413-418.
16. Boguniewicz M: Atopic dermatitis: beyond the itch that rashes. Immunol Allergy Clin North Am 2005;25:333-351, vii.